111 Inc ADRYI
Price$3.09

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value Valuation withheldbased on filings through 31 Dec 2025
Market Price $3.09Price as of 15 Oct 2026
Data confidenceNot applicable

This company reports its financial statements in one currency and its shares are priced in another, so the two cannot be compared as they stand. The valuation returns when the statements and the price have been brought to one currency.

Statements in CNY; share price in USD

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 5.0%/yr (balance of the path).5.0% per year
Years 6–10: glide to demonstrated growth own history 33.3%, capped at 20%
Per-year rates
Yr 65.0%Yr 75.0%Yr 85.0%Yr 95.0%Yr 105.0%
5.0% → 5.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 114.8%Yr 124.6%Yr 134.4%Yr 144.2%Yr 154.0%Yr 163.8%Yr 173.6%Yr 183.4%Yr 193.2%Yr 203.0%
5.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)33.3%
Discount rate (cost of equity) 8.2%
Volatility vs market (adjusted beta)0.73

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
Target111 Inc ADRYIHealth Care
Valuation
P/E—
P/S—
P/B—
EV / Revenue—
EV / EBITDA—
Profitability
Gross margin5.7%
Operating margin0.0%
Net margin-0.2%
FCF margin—
Returns
ROE—
ROA—
ROIC—
Growth
Revenue growth (YoY)-9.0%
5-yr fwd EPS growth—
Financial strength
Debt / Equity—
Current ratio—
Altman Z-Score—
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.